Expression of nucleostemin in prostate cancer and its effect on the proliferation of PC-3 cells

Chinese Medical Journal

Volumn 121, Issue 4, 2008, Pages 299-304

  Liu, Ran Lu ^a   Zhang, Zhi Hong ^a   Zhao, Wei Ming ^a   Wang, Meng ^a   Qi, Shi Yong ^a   Li, Jing ^a   Zhang, Yue ^a,b   Li, Sheng Zhi ^a,b   Xu, Yong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Institute of Urology   (China)

Author keywords

Nucleostemin; PC 3; Prostatic neoplasms; RNA interference

Indexed keywords

MESSENGER RNA; NUCLEOSTEMIN; ONCOPROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; CARRIER PROTEIN; NUCLEAR PROTEIN; NUCLEOSTEMIN PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN DU145; CELL STRAIN LNCAP; CELL STRAIN PC 3; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PLASMID; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING; ANIMAL; APOPTOSIS; CELL CYCLE; GENETICS; MOUSE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MALE; MICE; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; RNA, MESSENGER;

EID: 41649088833     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200802020-00004     Document Type: Article

References (19)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smiqal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
2. Crawford ED, Eisenberger MA, Mcleod DG; Spaulding JT, Benson R, Dorr FA, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989; 321: 419-424.
3. Tsai RY, Mckay RD. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 2002; 16: 2991-3003.
4. Liu SJ, Cai ZW, Liu YJ, Dong MY, Sun LQ, Hu GF, et al. Role of Nucleostemin in the growth regulation of gastric cancer, liver cancer and other malignancies. World J Gastroenterol 2004; 10: 1246-1249.
5. Sijin L, Ziwei C, Yajun L, Meiyu D, Hongwei Z, Guofa Hu, et al. The effect of knocking-down nucleostemin gene expression on the in vitro proliferation and in vivo tumorigenesis of HeLa cells. J Exp Clin Cancer Res 2004; 23: 529-538.
6. Yang L, Yeh SD, Xie S, Altuwaijri S, Ni J, Hu YC, et al. Androgen suppresses PML protein expression in prostate cancer CWR22R cells. Biochem Biophys Res Commun 2004; 314: 69-75.
7. Sun Y, Kim H, Paker M, Stetler-Stevenson WG, Colburn NH. Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells identification of a transfectant with increased tumorigenicity and invasiveness. Anticancer Res 1996; 16: 1-7.
8. Takaqi S, Mcfadden ML, Humphreys RE, Woda BA, Sairenji T. Detectionof 5-bromo-2-deoxyuridine(BrdUrd) incorporation with monoclonal antiBrdUrd antibody after deoxyribonuclease treatment. Cytometry 1993; 14: 640-648.
9. Yang H, Zhang J, Wu J, Shou C. Preparation and characterization of monoclonal antibodies against nucleostemin, a protein that controls cell proliferation in stem cells and cancer cells. Hybridoma (Larchmt) 2005; 24: 36-41.
10. Fan Y, Liu Z, Zhao S, Lou F, Nilsson S, Ekman P, et al. Nucleostemin mRNA is expressed in both normal and malignant renal tissues. Brit J Cancer 2006; 94: 1658-1662.
11. Yang HX, Jin GL, Meng L, Zhang JZ, Liu WB, Shou CC. Screening and identification of proteins interacting with nucleostemin. World J Gastroenterol 2005; 11: 4812-4814.
12. Tsai RY, Mckay RD. A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin. J Cell Biol 2005; 168: 179-184.
13. Tom Misteli. Going in GTP cycles in the nucleolus. J Cell Biol 2005; 168: 177-178.
14. van Bokhoven A, Varella-Garcia M, Korch C, Johannes WU, Smith EE, Miller HL, et al. Molecular characterization of human prostate carcinoma cell lines. Prostate 2003: 57: 205-225.
15. Rubbi CP, Milner J. Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus. Oncogene 2000; 19: 85-96.
16. Martens E, Stevenf. I, Janssens V, Vermeesch, J, Gotz J, Goris J, et al. Genomic organisation, chromosomal localization tissue distribution and developmental regulation of the PR61/B regulatory subunits of protein phosphatase 2A in mice. J Mol Biol 2004; 336: 971-986.
17. McCright B, Brothman AR, Virshup DM. Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 p12.Genomics 1996; 36: 168-170.
18. McCright B, Virshup DM. Identification of a new family of protein phosphatase 2A regulatory subunits. J Biol Chem 1995; 270: 26123-26128.
19. Zhong WD, He HC, Bi XC, Ou RB, Jiang SA, Liu LS. cDNA macroarray for analysis of gene expression profiles in prostate cancer. Chin Med J 2006; 119: 579-573.